Abstract
Background: Older age has a significant association with anaemia. However, this has not been adequately investigated in the context of specific comorbidities such as Type 2 Diabetes Mellitus (T2DM).
Objectives: To investigate the role of age in Normocytic Anaemia (NCA) and the adverse outcomes of NCA in T2DM.
Methods: Patients with NCA, either unexplained or related to Chronic Kidney Disease (CKD), were recruited from a diabetic clinic over six months. Anaemia was defined as a haemoglobin(Hb) < 130g/l for men and <120g/l for women. The relevant data were obtained by interviewing patients and review of medical records. Patients were followed for 12 months for pre-defined adverse outcomes.
Results: Of the 354 patients assessed, 203 were included (mean age 63.12 ± 13.62 years, males 49.8%). The prevalence of NCA was 24% (49). Older age had a significant univariate association with NCA (p < 0.001) and this remained significant (adjusted Odds Ratio (OR) 1.24, 95% CI 1.16- 5.29) after adjusting for estimated Glomerular Filtration Rate (eGFR) < 60ml/min/1.73m2, albuminuria and other potential confounders. Adjusting for eGFR as a continuous variable also confirmed this significant association (OR1.15, 95% CI 1.10-7.01). In the subgroup of patients aged ≥ 75 years, only older age was significantly associated with NCA. The incidence of all-cause mortality and composite cardiovascular/cerebrovascular events was similar in the anaemic and nonanaemic groups.
Conclusion: NCA is common in T2DM and has a significant association with older age independent of CKD. The anaemia is mild in most patients and appears to have a benign course.
Keywords: Older age, type 2 diabetes mellitus, normocytic anaemia, adverse outcomes, chronic kidney disease, cardiovascular events, mortality.
Graphical Abstract
[http://dx.doi.org/10.1053/j.ackd.2010.03.010] [PMID: 20610356]
[http://dx.doi.org/10.1111/j.1532-5415.1997.tb01509.x] [PMID: 9215333]
[http://dx.doi.org/10.1159/000213315] [PMID: 1612458]
[PMID: 22470008]
[http://dx.doi.org/10.1590/S0034-8910.2014048005039] [PMID: 25372162]
[http://dx.doi.org/10.1034/j.1600-0609.2003.00031.x] [PMID: 12605656]
[http://dx.doi.org/10.1111/bjh.12984] [PMID: 24935746]
[http://dx.doi.org/10.1159/000213283] [PMID: 1765284]
[http://dx.doi.org/10.1111/j.1532-5415.2005.53416.x] [PMID: 16078962]
[http://dx.doi.org/10.1016/j.amjmed.2005.06.039] [PMID: 16271918]
[http://dx.doi.org/10.1182/blood-2004-05-1812] [PMID: 15238427]
[http://dx.doi.org/10.1016/S0025-6196(12)61089-1] [PMID: 8035626]
[http://dx.doi.org/10.1007/BF03324220] [PMID: 7918735]
[http://dx.doi.org/10.1093/ndt/gfh248] [PMID: 15102962]
[http://dx.doi.org/10.12809/hkmj133814] [PMID: 23568938]
[http://dx.doi.org/10.2337/diaclin.32.4.158] [PMID: 25646941]
[http://dx.doi.org/10.2337/diacare.26.4.1164] [PMID: 12663591]
[PMID: 21422627]
[http://dx.doi.org/10.1007/s40520-016-0563-0] [PMID: 27038455]
[http://dx.doi.org/10.1007/BF03167944] [PMID: 16872024]
[http://dx.doi.org/10.1007/s00125-006-0254-z] [PMID: 16609874]
[http://dx.doi.org/10.1002/ajh.2830410406] [PMID: 1288287]
[http://dx.doi.org/10.1182/blood-2004-07-2599] [PMID: 15572589]
[http://dx.doi.org/10.1001/archinte.165.4.466] [PMID: 15738380]
[http://dx.doi.org/10.14740/jh411w]
[http://dx.doi.org/10.5958/0974-360X.2017.00003.8]
[http://dx.doi.org/10.1038/sj.clpt.6100146] [PMID: 17361126]
[http://dx.doi.org/10.5812/numonthly.19976] [PMID: 25695026]
[http://dx.doi.org/10.1002/pdi.1223]
[http://dx.doi.org/10.1111/j.1523-1755.2005.00226.x] [PMID: 15780101]
[http://dx.doi.org/10.4236/health.2014.612173]
[http://dx.doi.org/10.2337/diacare.24.3.495] [PMID: 11289474]
[http://dx.doi.org/10.1001/jama.281.18.1714] [PMID: 10328071]
[http://dx.doi.org/10.1002/ajh.23336] [PMID: 23044913]
[http://dx.doi.org/10.1046/j.1532-5415.2002.50313.x] [PMID: 12133021]
[http://dx.doi.org/10.1111/j.1532-5415.2006.00863.x] [PMID: 16970654]
[http://dx.doi.org/10.1093/ageing/afs031] [PMID: 22417980]
[http://dx.doi.org/10.1046/j.1445-5994.2003.00328.x] [PMID: 12534873]